USD 28.64
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 3.59 Billion SGD | -1.56% |
2022 | 3.65 Billion SGD | 11.16% |
2021 | 3.28 Billion SGD | 11.34% |
2020 | 2.94 Billion SGD | -9.01% |
2019 | 3.24 Billion SGD | 6.96% |
2018 | 3.03 Billion SGD | -11.37% |
2017 | 3.41 Billion SGD | 29.7% |
2016 | 2.63 Billion SGD | -2.09% |
2015 | 2.69 Billion SGD | -9.48% |
2014 | 2.97 Billion SGD | 15.91% |
2013 | 2.56 Billion SGD | 8.24% |
2012 | 2.37 Billion SGD | 26.32% |
2011 | 1.87 Billion SGD | -8.12% |
2010 | 2.04 Billion SGD | 1.95% |
2009 | 2 Billion SGD | 42.19% |
2008 | 1.4 Billion SGD | -30.85% |
2007 | 2.03 Billion SGD | 7.21% |
2006 | 1.9 Billion SGD | 36.21% |
2005 | 1.39 Billion SGD | 117.45% |
2004 | 641.71 Million SGD | -8.26% |
2003 | 699.49 Million SGD | -8.46% |
2002 | 764.18 Million SGD | -6.61% |
2001 | 818.3 Million SGD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 3.81 Billion SGD | 6.21% |
2024 Q2 | 3.81 Billion SGD | 0.0% |
2023 Q3 | 3.59 Billion SGD | 2.56% |
2023 Q1 | 3.5 Billion SGD | -4.02% |
2023 FY | 3.59 Billion SGD | -1.56% |
2023 Q4 | 3.59 Billion SGD | 0.0% |
2023 Q2 | 3.5 Billion SGD | 0.0% |
2022 Q3 | 3.65 Billion SGD | 10.31% |
2022 Q4 | 3.65 Billion SGD | 0.0% |
2022 Q1 | 3.3 Billion SGD | 0.77% |
2022 FY | 3.65 Billion SGD | 11.16% |
2022 Q2 | 3.3 Billion SGD | 0.0% |
2021 Q1 | 3.18 Billion SGD | 8.04% |
2021 Q2 | 3.18 Billion SGD | 0.0% |
2021 FY | 3.28 Billion SGD | 11.34% |
2021 Q3 | 3.28 Billion SGD | 3.05% |
2021 Q4 | 3.28 Billion SGD | 0.0% |
2020 Q4 | 2.94 Billion SGD | 0.0% |
2020 Q3 | 2.94 Billion SGD | 7.12% |
2020 Q2 | 2.75 Billion SGD | 0.0% |
2020 Q1 | 2.75 Billion SGD | -15.06% |
2020 FY | 2.94 Billion SGD | -9.01% |
2019 Q4 | 3.24 Billion SGD | 3.45% |
2019 FY | 3.24 Billion SGD | 6.96% |
2019 Q3 | 3.13 Billion SGD | -0.47% |
2019 Q1 | 3.16 Billion SGD | 4.38% |
2019 Q2 | 3.14 Billion SGD | -0.49% |
2018 Q1 | 3.32 Billion SGD | -2.82% |
2018 Q4 | 3.03 Billion SGD | -6.87% |
2018 Q3 | 3.25 Billion SGD | -0.29% |
2018 Q2 | 3.26 Billion SGD | -1.78% |
2018 FY | 3.03 Billion SGD | -11.37% |
2017 Q4 | 3.41 Billion SGD | 9.67% |
2017 Q3 | 3.11 Billion SGD | 3.51% |
2017 Q2 | 3.01 Billion SGD | 5.7% |
2017 Q1 | 2.84 Billion SGD | 8.09% |
2017 FY | 3.41 Billion SGD | 29.7% |
2016 FY | 2.63 Billion SGD | -2.09% |
2016 Q2 | 2.49 Billion SGD | -3.97% |
2016 Q4 | 2.63 Billion SGD | 3.55% |
2016 Q1 | 2.6 Billion SGD | -3.43% |
2016 Q3 | 2.54 Billion SGD | 1.96% |
2015 Q1 | 2.93 Billion SGD | -1.4% |
2015 Q3 | 2.58 Billion SGD | -13.97% |
2015 Q4 | 2.69 Billion SGD | 4.26% |
2015 FY | 2.69 Billion SGD | -9.48% |
2015 Q2 | 3 Billion SGD | 2.36% |
2014 Q2 | 2.77 Billion SGD | 4.36% |
2014 Q1 | 2.65 Billion SGD | 3.49% |
2014 FY | 2.97 Billion SGD | 15.91% |
2014 Q4 | 2.97 Billion SGD | 7.1% |
2014 Q3 | 2.77 Billion SGD | 0.2% |
2013 Q2 | 2.45 Billion SGD | -0.85% |
2013 Q1 | 2.48 Billion SGD | 4.65% |
2013 FY | 2.56 Billion SGD | 8.24% |
2013 Q4 | 2.56 Billion SGD | 2.47% |
2013 Q3 | 2.5 Billion SGD | 1.82% |
2012 FY | 2.37 Billion SGD | 26.32% |
2012 Q4 | 2.37 Billion SGD | 2.64% |
2012 Q3 | 2.3 Billion SGD | 6.92% |
2012 Q1 | 2.13 Billion SGD | 13.54% |
2012 Q2 | 2.16 Billion SGD | 1.39% |
2011 FY | 1.87 Billion SGD | -8.12% |
2011 Q4 | 1.87 Billion SGD | -4.94% |
2011 Q2 | 2.18 Billion SGD | 3.98% |
2011 Q3 | 1.97 Billion SGD | -9.72% |
2011 Q1 | 2.1 Billion SGD | 2.96% |
2010 FY | 2.04 Billion SGD | 1.95% |
2010 Q1 | 1.97 Billion SGD | -1.6% |
2010 Q2 | 2.01 Billion SGD | 2.07% |
2010 Q3 | 1.99 Billion SGD | -0.75% |
2010 Q4 | 2.04 Billion SGD | 2.28% |
2009 Q4 | 2 Billion SGD | 0.0% |
2009 FY | 2 Billion SGD | 42.19% |
2008 FY | 1.4 Billion SGD | -30.85% |
2007 FY | 2.03 Billion SGD | 7.21% |
2006 FY | 1.9 Billion SGD | 36.21% |
2005 FY | 1.39 Billion SGD | 117.45% |
2004 FY | 641.71 Million SGD | -8.26% |
2003 FY | 699.49 Million SGD | -8.46% |
2002 Q4 | 764.18 Million SGD | 0.0% |
2002 Q2 | 806.56 Million SGD | 0.0% |
2002 FY | 764.18 Million SGD | -6.61% |
2001 FY | 818.3 Million SGD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AstraZeneca PLC | 100.97 Billion USD | 96.442% |
Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | 96.224% |
CSPC Pharmaceutical Group Limited | 6.52 Billion USD | 44.924% |
Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -6848.979% |
Novartis AG | 99.94 Billion USD | 96.405% |
PT Kalbe Farma Tbk. | 1.75 Billion USD | -104.304% |